Outlook Therapeutics Inc
XNAS: OTLK
Outlook Therapeutics Inc Live Share Price Today, Share Analysis and Chart
about
Outlook Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications. The Company have received marketing authorization for an oph...
Read More
2.07
0.05
(2.48%)
1.6M
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Outlook Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..